Neurosurgery Clinical Trial
— NeuroHSIOfficial title:
A Prospective Observational Study to Evaluate the Use of an Intraoperative Hyperspectral Imaging System in Neurosurgery
NCT number | NCT05294185 |
Other study ID # | 284230 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | May 17, 2022 |
Est. completion date | August 2024 |
Brain surgery operations include brain tumour removal and blood vessel procedures. Each year in the UK, approximately 70,500 patients are diagnosed with a brain tumour, 5,000 of whom undergo surgery. Approximately 1,000 patients undergo blood vessel brain surgery. Brain tumour surgery involves removing as much of the tumour as safely as possible. If all tumour is removed, patients have significantly better outcomes and live longer. However, even with the best hands and the most modern technology currently available, it is often not possible to reliably identify tumour during surgery. Moreover, nerves and blood vessels cannot be reliably identified either during surgery. Yet, they need to be preserved to avoid brain damage. Due to this uncertainty and the need to balance risks, tumour is often left behind. Today, close to 30% of brain tumour patients require repeat surgery owing to tumour left behind during their first surgery. Further surgeries are more difficult, pose additional patient risks and lead to increased healthcare costs with often poor patient outcomes. Newly developed camera systems have the potential to enhance the surgeon's vision to reliably identify tumour and healthy brain structures. Hyperspectral imaging (HSI) is one of the most promising of such technologies. Its core ability is to provide very detailed and rich information that is invisible to the human eye. HSI has demonstrated the potential to provide crucial, but currently unavailable, information about tumour and critical brain structures during surgery. However, HSI data is very complex and requires advanced computer-processing for its interpretation. In this project, we will use a HSI imaging system to record data in 81 patient undergoing brain including 63 patients with brain tumours and 18 patients suffering from brain vessel abnormalities. Using this data we will develop key computer-processing features to enable real-time image interpretation.
Status | Recruiting |
Enrollment | 81 |
Est. completion date | August 2024 |
Est. primary completion date | August 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult patients aged 18 years and over - Patients with a diagnosis of a brain tumour (any type), AVM or aneurysm who are scheduled for elective surgery - Patients able to provide written informed consent Exclusion Criteria: - Patients under 18 years of age - Patients who have previously had brain surgery |
Country | Name | City | State |
---|---|---|---|
United Kingdom | King's College NHS Foundation Trust | London |
Lead Sponsor | Collaborator |
---|---|
King's College London |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Correlation of HSI data with histological analysis of the corresponding biopsied pathological tissue | To correlate HSI data with histological analysis of the corresponding biopsied pathological tissue and to correlate tissue perfusion and tissue oxygenation maps generated from the HSI data with the surgical timeline in patients undergoing neurovascular surgery. | 4-6 months | |
Secondary | Tissue perfusion and tissue oxygenation | Correlation of tissue perfusion and tissue oxygenation maps generated from the HSI data with the surgical timeline in patients undergoing neurovascular surgery | 36 months | |
Secondary | Safety of iHSI in Neurosurgery | Record of adverse events | 36 months | |
Secondary | AI algorithm specificity | Specificity of the AI algorithm to determine the histological nature of imaged tissue | 36 months | |
Secondary | Qualitative assessment | The impact that using the system has on surgical workflow (qualitative assessment) | 36 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03682198 -
Neuro-Ox 2018: Assessment of Cerebral Oxygenation Under Three Clinically Relevant Conditions
|
N/A | |
Withdrawn |
NCT00925093 -
Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection
|
Phase 1 | |
Completed |
NCT05264012 -
Incidence, Risk Factors and Impact of Significant Pain in Patients Undergoing Neurosurgery
|
||
Recruiting |
NCT05397574 -
Intraoperative Hyperspectral Imaging for Fluorescence Guided Surgery in Low Grade Gliomas
|
||
Completed |
NCT04153396 -
Preemptive Infiltration With Betamethasone and Ropivacaine for Postoperative Pain in Laminoplasty or Laminectomy
|
Phase 4 | |
Recruiting |
NCT03087981 -
Parameters Analysis in Neurosurgical Critical Patients Through Big Data Acquisition
|
N/A | |
Completed |
NCT01513213 -
Correlation of PaCO2 to the Inspired and Expired Oxygen Gradient
|
N/A | |
Recruiting |
NCT04034836 -
Parecoxib as an Adjuvant to Scalp Nerve Blocks for Relief of Post-craniotomy Pain
|
Phase 4 | |
Completed |
NCT03532256 -
Post-op Crowd Sourcing Health Data Via Text-messaging
|
||
Completed |
NCT05108337 -
Superficial Cervical Plexus Block for Postoperative Chronic Pain
|
N/A | |
Completed |
NCT02987816 -
Neurosurgical Skill Enhancement Using Transcranial Stimulation
|
N/A | |
Completed |
NCT03193905 -
Preventing Inadvertent Hypothermia in Patients Undergoing Major Spinal Surgery
|
N/A | |
Completed |
NCT00122096 -
Perioperative Inflammation and Cyclooxygenase 2 (COX-2)
|
Phase 4 | |
Recruiting |
NCT05874050 -
Arterial Pressure and Surgical Hemostasis in Elective Neurosurgery.
|
||
Completed |
NCT01122537 -
Characterization and Differential Diagnosis of Postneurosurgical Meningitis
|
N/A | |
Completed |
NCT04142203 -
Implementation of 23 Hour Surgery Model in a Tertiary Hospital
|
||
Completed |
NCT05169281 -
Distribution of Medication Disposal Packets - Acute Opioid Prescribing
|
N/A | |
Recruiting |
NCT06264037 -
The Experience in Neurorehabilitation Setting: a Qualitative Study
|
||
Recruiting |
NCT05860790 -
Prospective Validation of Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery
|
||
Completed |
NCT06068673 -
The Potential Impact of Clindamycin on Neurosurgery Patients.
|
N/A |